Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TIVAN LIMITED Capital/Financing Update 2026

Mar 11, 2026

65967_rns_2026-03-11_139470cb-2237-44fb-8a6d-88ea8a699268.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [596 x 125] intentionally omitted <==

12 March 2026

Tivan advances IPCM grant funding for Speewah Fluorite Project

  • Tivan has executed a Deed of Variation with the Commonwealth of Australia to bring forward $3 million in funding under the $7.4 million International Partnerships in Critical Minerals (“IPCM”) grant awarded to the Speewah Fluorite Project (“Project”) in Western Australia.

  • A $3 million funding tranche is now scheduled to be received in August 2026 and used to progress the Definitive Feasibility Study for the Project ahead of a final investment decision (“FID”); the Deed of Variation also aligns the grant agreement schedule with the current study schedule.

  • In addition to IPCM grant funding, Tivan has agreements in place with Sumitomo Corporation, JOGMEC and ETFS Capital to fund the progression of Project studies through to FID.

The Board of Tivan Limited (ASX: TVN) (“Tivan” or the “Company”) is pleased to advise that it has signed a Deed of Variation with the Commonwealth of Australia to bring forward funding of $3 million to August 2026 under the grant awarded to the Speewah Fluorite Project (“Project”) by the International Partnerships in Critical Minerals (“IPCM”) Program. Tivan was awarded a $7.4 million cash grant under the IPCM Program in support of funding the Feasibility Study (“FS”) and Definitive Feasibility Study (“DFS”) for the Project (see ASX announcement of 6 December 2024).

The Deed of Variation also aligns the updated schedule for completion of the FS and DFS with the grant agreement. Grant funding totalling $3.4 million (net of GST) has been received to date, including a recent payment of $0.15 million in February 2026. With the new $3 million tranche of funding in August 2026, the balance of grant funding of approximately $1 million is scheduled to be received following completion of the DFS and final grant reporting.

Tivan announced in February it had submitted a confidential draft of the FS to its joint venture partners, Sumitomo Corporation and JOGMEC, and strategic partner ETFS Capital Limited (“ETFSC”) (see ASX announcement of 23 February 2026). Subject to unanimous adoption of the FS, Sumitomo Corporation and JOGMEC will make a further equity investment of $5 million in the joint venture (see ASX announcements of 7 May and 21 July 2025). ETFSC completed an initial investment of $11.3 million for the Project in January 2026 (see ASX announcements of 17 November 2025 and 7 January 2026).

The IPCM grant funding, combined with the funding from Sumitomo Corporation, JOGMEC and ETFSC, provides a comprehensive funding plan to progress the Project through to a final investment decision.

Comment from Tivan Executive Chairman

Mr Grant Wilson commented:

“The diversified funding sources that Tivan has drawn together to advance the Speewah Fluorite Project to a final investment decision provide certainty and stability to our planning and execution. We extend thanks to the team at the Department of Industry, Science and Resources for their ongoing engagement and support”.

This announcement has been approved by the Board of the Company.

==> picture [596 x 69] intentionally omitted <==

==> picture [596 x 128] intentionally omitted <==

Inquiries:

Nicholas Ong

Company Secretary: + 61 8 9486 4036 Email: [email protected]

Forward looking statement

This announcement contains certain “forward-looking statements” and comments about future matters. Forward-looking statements can generally be identified by the use of forward-looking words such as, “expect”, “anticipate”, “likely”, “intend”, “should”, “estimate”, “target”, “outlook”, and other similar expressions and include, but are not limited to, the timing, outcome and effects of the future studies, project development and other work. Indications of, and guidance or outlook on, future earnings or financial position or performance are also forward-looking statements. You are cautioned not to place undue reliance on forward-looking statements. Any such statements, opinions and estimates in this announcement speak only as of the date hereof, are preliminary views and are based on assumptions and contingencies subject to change without notice. Forwardlooking statements are provided as a general guide only. There can be no assurance that actual outcomes will not differ materially from these forward-looking statements. Any such forward looking statement also inherently involves known and unknown risks, uncertainties and other factors and may involve significant elements of subjective judgement and assumptions that may cause actual results, performance and achievements to differ. Except as required by law the Company undertakes no obligation to finalise, check, supplement, revise or update forward-looking statements in the future, regardless of whether new information, future events or results or other factors affect the information contained in this announcement.

==> picture [596 x 68] intentionally omitted <==